Abstract
A series of 2,3,5-trisubstituted and 1,2,3,5-tetrasubstituted indoles is synthesized by Fisher or Bischler method, followed by alkylation with an appropriate alkyl or aryl halide. Two compounds exhibit non-competitive antagonism towards GluK1 and six – towards GluK2 receptor. The values of IC50 are in micromolar range. The investigated compounds belong to the most active GluK1 non-competitive inhibitors and are the first known negative allosteric modulators of GluK2 receptor. The observed pattern of activity is rationalized by molecular modelling, in particular by construction of the pharmacophore model.
Keywords: Allosteric modulators, Indole derivatives, Glutamate receptors, Kainate receptors, Molecular modelling, Non-competitive antagonists of kainate receptors, ionotropic glutamate receptors, Alzheimer’s disease, NMDA receptor antagonists, Zindoxifene
Letters in Drug Design & Discovery
Title:Novel Non-Competitive Antagonists of Kainate GluK1/GluK2 Receptors
Volume: 9 Issue: 10
Author(s): Agnieszka Anna Kaczor, Christiane Kronbach, Klaus Unverferth, Kalevi Pihlaja, Kirsti Wiinamaki, Jari Sinkkonen, Urszula Kijkowska-Murak, Tomasz Wrobel, Tomasz Stachal and Dariusz Matosiuk
Affiliation:
Keywords: Allosteric modulators, Indole derivatives, Glutamate receptors, Kainate receptors, Molecular modelling, Non-competitive antagonists of kainate receptors, ionotropic glutamate receptors, Alzheimer’s disease, NMDA receptor antagonists, Zindoxifene
Abstract: A series of 2,3,5-trisubstituted and 1,2,3,5-tetrasubstituted indoles is synthesized by Fisher or Bischler method, followed by alkylation with an appropriate alkyl or aryl halide. Two compounds exhibit non-competitive antagonism towards GluK1 and six – towards GluK2 receptor. The values of IC50 are in micromolar range. The investigated compounds belong to the most active GluK1 non-competitive inhibitors and are the first known negative allosteric modulators of GluK2 receptor. The observed pattern of activity is rationalized by molecular modelling, in particular by construction of the pharmacophore model.
Export Options
About this article
Cite this article as:
Anna Kaczor Agnieszka, Kronbach Christiane, Unverferth Klaus, Pihlaja Kalevi, Wiinamaki Kirsti, Sinkkonen Jari, Kijkowska-Murak Urszula, Wrobel Tomasz, Stachal Tomasz and Matosiuk Dariusz, Novel Non-Competitive Antagonists of Kainate GluK1/GluK2 Receptors, Letters in Drug Design & Discovery 2012; 9 (10) . https://dx.doi.org/10.2174/1570180811209050891
DOI https://dx.doi.org/10.2174/1570180811209050891 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
L-Valine and L-Proline - Solid-State IR-LD Spectroscopic Study
Protein & Peptide Letters The Role of Sialylation in Respiratory Viral Infection and Treatment
Current Medicinal Chemistry Pharmacological Cyclin-Dependent Kinase Inhibitors (PCIs) as Potential Antiviral Drugs
Anti-Infective Agents in Medicinal Chemistry Delivery of Neurotherapeutics Across the Blood Brain Barrier in Stroke
Current Pharmaceutical Design Electrically-Assisted Nucleic Acids Delivery to Tissues In Vivo: Where Do We Stand?
Current Pharmaceutical Design Peptide Microarrays: Next Generation Biochips for Detection, Diagnostics and High-Throughput Screening
Current Pharmaceutical Design Ultrasound-Based Multimodal Molecular Imaging and Functional Ultrasound Contrast Agents
Current Pharmaceutical Design Hyaluronic Acid: The Reason for Its Variety of Physiological and Biochemical Functional Properties
Applied Clinical Research, Clinical Trials and Regulatory Affairs Protein Kinase C – Possible Therapeutic Target to Treat Cardiovascular Diseases
Cardiovascular & Hematological Disorders-Drug Targets Haptotactic Gradients for Directed Cell Migration: Stimulation and Inhibition Using Soluble Factors
Combinatorial Chemistry & High Throughput Screening 11-Phenylundeca-5Z,9Z-dienoic Acid: Stereoselective Synthesis and Dual Topoisomerase I/IIα Inhibition
Current Cancer Drug Targets Plant Sterols and Stanols as Cholesterol-Lowering Ingredients in Functional Foods
Recent Patents on Food, Nutrition & Agriculture A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets Rapid and Solventless Analysis of Polychlorinated Biphenyls in Packaged Milk Using Gas Chromatography
Current Chromatography Synthetic and Biological Vesicular Nano-Carriers Designed for Gene Delivery
Current Pharmaceutical Design Simultaneous Assay of Ascorbate and Urate Antioxidants in Human Blood Serum Using PEDOT- Based Electrochemical Microsensor
Combinatorial Chemistry & High Throughput Screening A High-Complexity, Multiplexed Solution-Phase Assay for Profiling Protease Activity on Microarrays
Combinatorial Chemistry & High Throughput Screening Applications of Metabonomics in Pesticide Toxicology
Current Drug Metabolism Antiviral Drug Discovery Targeting to Viral Proteases
Current Pharmaceutical Design Mango Polyphenols and Its Protective Effects on Diseases Associated to Oxidative Stress
Current Pharmaceutical Biotechnology